S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
BREAKING: Tiny biotech successfully treats blindness (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
BREAKING: Tiny biotech successfully treats blindness (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
BREAKING: Tiny biotech successfully treats blindness (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
BREAKING: Tiny biotech successfully treats blindness (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
BREAKING: Tiny biotech successfully treats blindness (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people

iRhythm Technologies (IRTC) Stock Forecast, Price & News

$85.50
-1.80 (-2.06%)
(As of 09/22/2023 ET)
Compare
Today's Range
$84.73
$87.99
50-Day Range
$85.50
$116.39
52-Week Range
$84.73
$140.23
Volume
397,612 shs
Average Volume
317,320 shs
Market Capitalization
$2.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$139.22

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
62.8% Upside
$139.22 Price Target
Short Interest
Bearish
7.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.68mentions of iRhythm Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.03) to ($2.30) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

344th out of 963 stocks

Surgical & Medical Instruments Industry

45th out of 97 stocks


IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Price History

IRTC Stock News Headlines

iRhythm Technologies (NASDAQ:IRTC) Hits New 1-Year Low at $85.01
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Truist Financial Remains a Buy on Irhythm Technologies (IRTC)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Irhythm Technologies (IRTC) Gets a Buy from Truist Financial
iRhythm Technologies (NASDAQ: IRTC)
What 11 Analyst Ratings Have To Say About iRhythm Technologies
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings
8/03/2023
Today
9/24/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,793
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$139.22
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$116.00
Forecasted Upside/Downside
+62.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Net Income
$-116,150,000.00
Pretax Margin
-21.84%

Debt

Sales & Book Value

Annual Sales
$410.92 million
Book Value
$7.96 per share

Miscellaneous

Free Float
30,447,000
Market Cap
$2.61 billion
Optionable
Optionable
Beta
1.33
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Quentin S. Blackford (Age 44)
    Pres, CEO & Director
    Comp: $2.15M
  • Mr. Brice Bobzien CPA (Age 44)
    Chief Financial Officer
    Comp: $685.12k
  • Dr. Minang P. Turakhia M.D. (Age 49)
    M.S., Chief Medical & Scientific Officer and Exec. VP of Product Innovation
    Comp: $1M
  • Mr. Patrick Michael Murphy J.D. (Age 44)
    Chief Bus. & Legal Officer
    Comp: $1.28M
  • Mr. Douglas J. DevineMr. Douglas J. Devine (Age 53)
    Exec. Advisor
    Comp: $800k
  • Mr. Chad M. Patterson (Age 41)
    Chief Commercial Officer
    Comp: $771.51k
  • Mr. Marc Rosenbaum (Age 51)
    Sr. VP of Fin. & Chief Accounting Officer
  • Mr. Mark J. Day Ph.D. (Age 52)
    Chief Technology Officer
  • Mr. Daniel G. WilsonMr. Daniel G. Wilson (Age 40)
    Exec. VP of Corp. Devel. & Investor Relations
  • Ms. Sumi Shrishrimal (Age 44)
    Exec. VP & Chief Risk Officer













IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2023?

9 brokerages have issued twelve-month price targets for iRhythm Technologies' shares. Their IRTC share price forecasts range from $116.00 to $165.00. On average, they expect the company's share price to reach $139.22 in the next twelve months. This suggests a possible upside of 62.8% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2023?

iRhythm Technologies' stock was trading at $93.67 at the beginning of the year. Since then, IRTC shares have decreased by 8.7% and is now trading at $85.50.
View the best growth stocks for 2023 here
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, August, 3rd. The company reported ($0.61) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.75) by $0.14. The business earned $124.13 million during the quarter, compared to analysts' expectations of $120.03 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 41.92% and a negative net margin of 21.95%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.00 million-$490.00 million, compared to the consensus revenue estimate of $483.78 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Sands Capital Management LLC (7.80%), BlackRock Inc. (7.76%), Capital Research Global Investors (7.48%), Artisan Partners Limited Partnership (5.24%), JPMorgan Chase & Co. (4.05%) and Mackenzie Financial Corp (4.01%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $85.50.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $2.61 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.28) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,793 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -